Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy.
about
IL-34 induces the differentiation of human monocytes into immunosuppressive macrophages. antagonistic effects of GM-CSF and IFNγCancer Stem Cells and Macrophages: Implications in Tumor Biology and Therapeutic StrategiesMesenchymal Stem Cell-Mediated Effects of Tumor Support or SuppressionRegulation of epithelial-mesenchymal transition by tumor-associated macrophages in cancerBreast Cancer-Derived Extracellular Vesicles: Characterization and Contribution to the Metastatic PhenotypeDeveloping Extracellular Matrix Technology to Treat Retinal or Optic Nerve Injury(1,2,3)The complex and central role of interferon-γ in graft-versus-host disease and graft-versus-tumor activityOn the origin of cancer metastasisImmune escape mechanisms in colorectal cancer pathogenesis and liver metastasisTumour hypoxia promotes melanoma growth and metastasis via High Mobility Group Box-1 and M2-like macrophagesTargeting Tumor Cells with Anti-CD44 Antibody Triggers Macrophage-Mediated Immune Modulatory Effects in a Cancer Xenograft ModelNETosis in Cancer - Platelet-Neutrophil Crosstalk Promotes Tumor-Associated PathologyMyeloid cells in the tumor microenvironment: Role of adenosineNew Mechanisms of Tumor-Associated Macrophages on Promoting Tumor Progression: Recent Research Advances and Potential Targets for Tumor ImmunotherapyAlong the Axis between Type 1 and Type 2 Immunity; Principles Conserved in Evolution from Fish to MammalsCysteinyl leukotrienes and their receptors: bridging inflammation and colorectal cancerOrchestration of angiogenesis by immune cellsReciprocal modulation between microglia and astrocyte in reactive gliosis following the CNS injuryThe Intercellular Metabolic Interplay between Tumor and Immune CellsCharacteristics of the alternative phenotype of microglia/macrophages and its modulation in experimental gliomasMathematical modeling of Interleukin-35 promoting tumor growth and angiogenesisAlternatively activated macrophages and collagen remodeling characterize the postpartum involuting mammary gland across speciesAdult mouse model of early hepatocellular carcinoma promoted by alcoholic liver diseaseIdentification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cordThe senescence-associated secretory phenotype: the dark side of tumor suppressionTumor-associated macrophages of the M2 phenotype contribute to progression in gastric cancer with peritoneal dissemination.Spatiotemporal control of gene expression in bone-marrow derived cells of the tumor microenvironment induced by MRI guided focused ultrasound.Bone marrow-derived angiogenic cells restore lung alveolar and vascular structure after neonatal hyperoxia in infant mice.Longitudinal confocal microscopy imaging of solid tumor destruction following adoptive T cell transfer.Therapeutic effects of anti-CD115 monoclonal antibody in mouse cancer models through dual inhibition of tumor-associated macrophages and osteoclasts.Senescence regulates macrophage activation and angiogenic fate at sites of tissue injury in mice.Stimulated monocyte IL-6 secretion predicts survival of patients with head and neck squamous cell carcinomaAnalysis of the effects of exposure to acute hypoxia on oxidative lesions and tumour progression in a transgenic mouse breast cancer model.The Fate of the Tumor in the Hands of Microenvironment: Role of TAMs and mTOR Pathway.Cellular profile of the peritumoral inflammatory infiltrate in squamous cells carcinoma of oral mucosa: Correlation with the expression of Ki67 and histologic grading.Interleukin-10 promotes pathological angiogenesis by regulating macrophage response to hypoxia during development.IL-12 can target human lung adenocarcinoma cells and normal bronchial epithelial cells surrounding tumor lesions.CCL2 and interleukin-6 promote survival of human CD11b+ peripheral blood mononuclear cells and induce M2-type macrophage polarizationTumor-associated macrophages infiltrate plasmacytomas and can serve as cell carriers for oncolytic measles virotherapy of disseminated myeloma.Inhibition of lung cancer growth by HangAmDan-B is mediated by macrophage activation to M1 subtype
P2860
Q24317213-B754A84F-627E-416F-9440-7FEAB545D498Q26765342-EA04CA00-D7E0-450E-BEC4-E351192B3EF0Q26773413-C5114CB5-EA0C-4255-99B1-E07A0EB52BABQ26773786-072D96DF-2845-49F9-8DE0-7BBF90C0738CQ26776113-72CFFD4F-73A1-4E19-AC3C-DB194FC10253Q26781911-C071958E-9E30-4C51-B491-28C8DB76B55EQ26851545-FA50DE19-BBBF-4A56-846E-0611DA1B828EQ26865675-5A27FB65-F39D-4E02-B977-6CFE0E6D0878Q27002388-6344B814-087E-40A7-911E-BB610BBF7219Q27325462-27DECA0F-0343-49F5-8237-64D9B1C5B9FEQ27333471-D5248A82-566F-4E98-BC48-1875408D2BF4Q28066483-E52DD067-4CDB-4E0D-BD9F-1987ACCCBADDQ28069621-6D08AC54-91FD-438A-B545-E6A172E6952AQ28072045-1DB767AA-1C06-416D-9C88-B4F124697DC3Q28083360-9B12E70D-3273-48B3-A2F1-88D3189C55BCQ28308101-4C9B523C-3C8A-4358-B6AA-BA3A486DCA61Q28389236-94FC19BC-681E-49B3-80A6-AB17EC5FF6D4Q28389274-45A4E068-B172-4150-B42F-9158DA4429FAQ28391079-6A0F6337-DBFE-4D7C-877B-9D682E9F70E1Q28476714-A4CAEE45-6FEE-4E4A-AD59-6EB7A65763BBQ28544606-942AFD59-F15F-41D0-A6F8-F33B3F05123AQ28576808-EF30906C-CFB7-453D-82B4-5B8310EEC4ABQ28834514-DF8495B3-E847-4681-9986-580700607C12Q29619388-72BA51C6-C861-4AAA-AD86-86CE6F24CEE3Q29620106-606167E8-1879-4176-8E20-32AD5D65FF87Q30372640-A7379044-0BE2-4BDA-A653-369188BB7F53Q30393017-C8061CD2-ADFA-4163-9BBA-E9FD21BC140BQ30493673-633BCAE6-16CE-47CC-8B1F-18FD9F45D5DCQ30565493-8DD4B6AB-EDBC-4F6E-9EAE-ACCDACE54792Q31137466-DCEA1B6A-E816-4F20-9B1C-C60073A73933Q33304653-D43B4177-3791-4B01-BB07-759A0BB45377Q33317415-A91A0197-3CD0-40B9-B641-2335878147D5Q33338282-BA5417FC-23C0-4467-8B62-A4756E6FACF0Q33364555-68524E4C-A045-40B2-A7FD-395F5BE92028Q33365818-332F3C4F-8545-4C46-9905-C19C78CCF93EQ33375711-2F9FA196-06F7-4A95-871B-2B1F05116A55Q33479161-D102D60E-7BC7-44A9-BBA5-1A28F253FC78Q33553562-6F664BAC-3287-47CC-A7C1-B30CA3B568F3Q33585559-93E36C9A-2C8D-4393-BD69-45C93CC2D106Q33598678-956CA578-C075-4BBE-8712-FDABD42DBEAD
P2860
Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Tumour-associated macrophages ...... argets of anti-cancer therapy.
@ast
Tumour-associated macrophages ...... argets of anti-cancer therapy.
@en
type
label
Tumour-associated macrophages ...... argets of anti-cancer therapy.
@ast
Tumour-associated macrophages ...... argets of anti-cancer therapy.
@en
prefLabel
Tumour-associated macrophages ...... argets of anti-cancer therapy.
@ast
Tumour-associated macrophages ...... argets of anti-cancer therapy.
@en
P1476
Tumour-associated macrophages ...... argets of anti-cancer therapy.
@en
P2093
Antonio Sica
Paola Allavena
P304
P356
10.1016/J.EJCA.2006.01.003
P577
2006-03-07T00:00:00Z